Reactive arthritis

Scand J Rheumatol. 2005 Jul-Aug;34(4):251-9. doi: 10.1080/03009740500202540.

Abstract

Reactive arthritis (ReA) was known as Reiter's disease or Fiessinger-Leroy disease for nearly 100 years. However, during the past 30 years the disease has been known as reactive arthritis, a member of the spondyloarthritis family. Despite knowing the initiating event (infection) and genetic constitution (many patients have HLA-B27) of ReA, a model of interplay between environment and genetics, its pathogenesis is still incompletely known. This review covers the epidemiology, clinical features, treatment, and prognosis of ReA.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adult
  • Age Distribution
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis, Reactive / drug therapy
  • Arthritis, Reactive / epidemiology*
  • Arthritis, Reactive / immunology
  • Arthritis, Reactive / microbiology*
  • Drug Therapy, Combination
  • Female
  • Finland / epidemiology
  • HLA-B27 Antigen / immunology*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prognosis
  • Prohibitins
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • HLA-B27 Antigen
  • PHB2 protein, human
  • Prohibitins